Intellectual Property
Apr. 13, 2013
Human gene patents, biotech industry face Supreme Court scrutiny
The U.S. Supreme Court is set to consider whether scientifically altered human genes are patentable in what several legal observers are calling a crucial test for biotechnology companies.
Daily Journal Staff Writer
The U.S. Supreme Court is set to consider whether scientifically altered human genes are patentable in what several legal observers are calling a crucial test for biotechnology companies.
The decision could determine if and to what extent biotech companies can convert their genetic research on DNA into valuable assets through the U.S. Patent and Trademark Office.
"I think it's a very i...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In